Citadel Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Sell
56,000
-12,200
-18% -$525K ﹤0.01% 5706
2025
Q4
$2.99M Sell
68,200
-15,400
-18% -$637K ﹤0.01% 5167
2025
Q3
$3.45M Buy
83,600
+600
+0.7% +$24.1K ﹤0.01% 5043
2025
Q2
$3.66M Sell
83,000
-29,400
-26% -$1.18M ﹤0.01% 4638
2025
Q1
$4.15M Sell
112,400
-62,800
-36% -$2.24M ﹤0.01% 4198
2024
Q4
$5.83M Sell
175,200
-61,200
-26% -$1.99M ﹤0.01% 3716
2024
Q3
$6.13M Buy
236,400
+60,000
+34% +$1.49M ﹤0.01% 3627
2024
Q2
$3.96M Buy
176,400
+47,500
+37% +$1.05M ﹤0.01% 4115
2024
Q1
$3.06M Sell
128,900
-345,200
-73% -$7.67M ﹤0.01% 4755
2023
Q4
$11.4M Buy
474,100
+112,600
+31% +$2.45M ﹤0.01% 2669
2023
Q3
$7.9M Buy
361,500
+157,100
+77% +$3.29M ﹤0.01% 2983
2023
Q2
$3.91M Buy
204,400
+98,500
+93% +$1.9M ﹤0.01% 4028
2023
Q1
$2.06M Sell
105,900
-84,400
-44% -$1.47M ﹤0.01% 5318
2022
Q4
$3.05M Buy
190,300
+63,500
+50% +$1.04M ﹤0.01% 4721
2022
Q3
$1.99M Sell
126,800
-117,500
-48% -$2.27M ﹤0.01% 5603
2022
Q2
$5.09M Buy
244,300
+66,400
+37% +$1.37M ﹤0.01% 3757
2022
Q1
$4.03M Sell
177,900
-7,600
-4% -$148K ﹤0.01% 4590
2021
Q4
$3.39M Sell
185,500
-11,600
-6% -$222K ﹤0.01% 5107
2021
Q3
$4.17M Buy
197,100
+46,400
+31% +$862K ﹤0.01% 4657
2021
Q2
$2.75M Sell
150,700
-46,200
-23% -$1.08M ﹤0.01% 5817
2021
Q1
$4.45M Buy
196,900
+43,200
+28% +$976K ﹤0.01% 4517
2020
Q4
$3.08M Sell
153,700
-48,300
-24% -$1.01M ﹤0.01% 4544
2020
Q3
$4.94M Sell
202,000
-52,700
-21% -$1.23M ﹤0.01% 3172
2020
Q2
$6.05M Sell
254,700
-163,700
-39% -$3.79M ﹤0.01% 2825
2020
Q1
$7.21M Sell
418,400
-6,100
-1% -$112K ﹤0.01% 2247
2019
Q4
$7.48M Buy
424,500
+94,900
+29% +$1.61M ﹤0.01% 2558
2019
Q3
$5.83M Buy
329,600
+15,800
+5% +$320K ﹤0.01% 2899
2019
Q2
$6.71M Sell
313,800
-101,400
-24% -$2.13M ﹤0.01% 2685
2019
Q1
$9.88M Buy
415,200
+135,800
+49% +$3.1M ﹤0.01% 2092
2018
Q4
$5.5M Sell
279,400
-46,400
-14% -$827K ﹤0.01% 2652
2018
Q3
$5.77M Sell
325,800
-16,000
-5% -$312K ﹤0.01% 2808
2018
Q2
$7.36M Buy
341,800
+208,700
+157% +$4.32M ﹤0.01% 2276
2018
Q1
$2.95M Sell
133,100
-70,300
-35% -$1.94M ﹤0.01% 3163
2017
Q4
$6.18M Buy
203,400
+55,100
+37% +$1.47M ﹤0.01% 2227
2017
Q3
$3.59M Sell
148,300
-8,000
-5% -$213K ﹤0.01% 2690
2017
Q2
$3.85M Buy
156,300
+39,500
+34% +$836K ﹤0.01% 2394
2017
Q1
$2.53M Sell
116,800
-90,300
-44% -$1.84M ﹤0.01% 2790
2016
Q4
$3.09M Sell
207,100
-11,000
-5% -$159K ﹤0.01% 2470
2016
Q3
$2.79M Buy
218,100
+92,400
+74% +$999K ﹤0.01% 2578
2016
Q2
$982K Buy
125,700
+9,800
+8% +$56.5K ﹤0.01% 3569
2016
Q1
$464K Sell
115,900
-131,300
-53% -$556K ﹤0.01% 4515
2015
Q4
$1.39M Buy
247,200
+108,200
+78% +$605K ﹤0.01% 3181
2015
Q3
$780K Sell
139,000
-147,000
-51% -$800K ﹤0.01% 4157
2015
Q2
$1.07M Buy
286,000
+166,600
+140% +$542K ﹤0.01% 3872
2015
Q1
$307K Buy
119,400
+36,200
+44% +$84K ﹤0.01% 5613
2014
Q4
$120K Sell
83,200
-167,100
-67% -$260K ﹤0.01% 6491
2014
Q3
$383K Buy
250,300
+213,000
+571% +$684K ﹤0.01% 4971
2014
Q2
$126K Sell
37,300
-21,400
-36% -$73.9K ﹤0.01% 6031
2014
Q1
$208K Buy
58,700
+44,800
+322% +$305K ﹤0.01% 5471
2013
Q4
$85K Sell
13,900
-2,100
-13% -$11.6K ﹤0.01% 5729
2013
Q3
$93K Sell
16,000
-7,600
-32% -$39.3K ﹤0.01% 5398
2013
Q2
$107K Buy
+23,600
New +$112K ﹤0.01% 5173

Other funds holding EXEL

Citadel Advisors's EXEL Position: Q1 2026 in Review

Citadel Advisors increased its Exelixis (EXEL) stake by 67% in Q1 2026, buying an estimated $14M and bringing the position to 812,195 shares worth $34.8M. The position accounts for 0.01% of the portfolio, ranked #1710.

Citadel Advisors first reported a position in EXEL in Q2 2013 and has held it in 49 quarters since. The position peaked at $82.6M in Q1 2021. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Citadel Advisors held 812,195 shares of Exelixis worth $34.8M as of Q1 2026.
  • Citadel Advisors bought 326,318 Exelixis shares in Q1 2026, an estimated $14M.
  • Exelixis made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1710 holding.
  • Citadel Advisors first reported a position in Exelixis in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Exelixis position peaked at $82.6M in Q1 2021.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.